Abstract Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …

Abstract Purpose of Review The outbreak of the novel coronavirus disease 2019 (COVID-
19) has emerged to be the biggest global health threat worldwide, which has now infected …

Patients with cancer, in particular patients with hematologic malignancies, are at increased
risk for critical illness upon COVID-19. We here assessed antibody as well as CD4+ and …

Abstract As of 10 April 2020, New York State had 180,458 cases of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and 9,385 reported deaths. Patients with cancer …

Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current
or past history of cancer facing disparate consequences at every stage of the cancer …

Abstract New York State had 180,458 cases of SARS-CoV-2 and 9385 reported deaths as of
April 10 th, 2020. Patients with cancer comprised 8.4% of deceased individuals 1 …

ORIgINAl ARTIClE Wang, M. et al. KTE-X19 CAR T-cell therapy in relapsed or refractory
mantle-cell lymphoma. N. Engl. J. Med. 383, 1331–1342 (2020) 4.7% had severe clinical …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and its clinical
manifestation, the coronavirus disease 2019 (COVID19) have rapidly spread across the …

The SARS-CoV-2 pandemic significantly affected oncology practice across the globe. There
is uncertainty as to the contribution of patients' demographics and oncologic features to …